IShares Nasdaq Biotechnology ETF Net Income 1970-1969 | IBB

IShares Nasdaq Biotechnology ETF annual/quarterly net income history and growth rate from 1970 to 1969. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • IShares Nasdaq Biotechnology ETF net income for the quarter ending December 31, 1969 was $0M, a NAN% increase year-over-year.
  • IShares Nasdaq Biotechnology ETF net income for the twelve months ending December 31, 1969 was $0M, a NAN% increase year-over-year.
  • IShares Nasdaq Biotechnology ETF annual net income for was $0B, a NAN% decline from .
  • IShares Nasdaq Biotechnology ETF annual net income for was $0B, a NAN% decline from .
  • IShares Nasdaq Biotechnology ETF annual net income for was $0B, a NAN% decline from .
IShares Nasdaq Biotechnology ETF Annual Net Income
(Millions of US $)
IShares Nasdaq Biotechnology ETF Quarterly Net Income
(Millions of US $)
Sector Industry Market Cap Revenue
Finance Finance - Publicly Traded Investment Trusts $6.445B $0.000B
The ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index.
Stock Name Country Market Cap PE Ratio
Sea (SE) Singapore $9.108B 0.00
Adams Diversified Equity Fund (ADX) United States $1.670B 0.00
Lifestyle Holdings (LFSYY) Hong Kong, SAR China $1.520B 0.00
Compass Diversified Holdings (CODI) United States $1.168B 14.23
Taiwan Fund (TWN) United States $0.155B 0.00
Equus Total Return (EQS) United States $0.022B 0.00
GSV Capital Corp (SSSS) United States $0.000B 0.00